Listen to patients. Visible voices. Clearer Lyme diagnosis.

With new Lyme diagnostics emerging, how might we make Lyme and other tickborne disease diagnoses more visible and transparent so patients and clinicians can understand and act on complex information — and learn from real voices?

Overview

The LymeX Visible Voices Prize is a national prize competition with a $250,000 prize pool to elevate patient experiences and improve understanding of Lyme and tickborne disease diagnosis. It mobilizes patients, caregivers, clinicians, and innovators to create clear, trusted educational resources that address urgent gaps in awareness and care.

Lyme disease is the most common vector-borne disease in the United States and affects hundreds of thousands of Americans each year. Still, many experience delayed or unclear Lyme disease diagnoses due to limited awareness, evolving testing options, and communication gaps. The result is prolonged illness, debilitating complications, increased health care costs, inconsistent care pathways, and reduced quality of life for patients and family caregivers.

This prize enables participants to transform lived experience and emerging science into practical, trusted resources. Participants retain full ownership of the materials and intellectual property they create. Final submissions are shared publicly under Creative Commons licenses, allowing broad reuse with attribution. The Federal Government provides a platform to elevate and amplify these solutions — turning lived experience into widely accessible, high-impact resources.

What is the LymeX Visible Voices Prize?

This is a national call to action, sponsored by the U.S. Department of Health and Human Services (HHS) and the LymeX Innovation Accelerator. This prize builds upon the existing LymeX Diagnostics Prize — now in Phase 4 — and is the first LymeX prize in four years open to all U.S. citizens and organizations.

What participants created

Participants created clear, evidence-based educational materials to deliver real-world impact. Teams designed resources that improve understanding, communication, and decision-making—translating complexity into clarity. Materials had to be based on federal government sources and peer-reviewed literature and be immediately understandable and usable by the intended audience without specialized training.

Each submission focused on one of four challenge areas:

  • Diagnostics Information and Resources: Explain available and emerging Lyme and tickborne disease tests in plain language, including what they measure, how they differ, and their limitations.
  • Provider-Facing Educational Materials: Equip frontline providers with practical, evidence-based resources aligned with HHS, CDC, and public health guidance.
  • Patient Education Tools: Help patients understand symptoms, testing pathways, and next steps so they can navigate care with confidence.
  • Community-Informed Insights: Capture and translate lived experiences into actionable insights that highlight gaps, needs, and opportunities in the diagnostic journey.

The LymeX Visible Voices Prize, conducted under the America COMPETES Act and HHS Challenge rules, was open to eligible U.S. citizens and U.S. organizations.

Outcomes

HHS received 50 submissions, with 40 eligible entries advancing to evaluation, and announced 16 winners on October 30, 2026. These outputs aim to improve understanding of Lyme diagnostics, elevate patient voices, and support more informed care decisions.

All submitted entries may be shared publicly under Creative Commons licenses and may be amplified by HHS, CDC, federal partners, LymeX affiliates, and others to promote awareness and improve understanding of Lyme and tickborne disease diagnostics. Participants retain ownership of their work while enabling broad public reuse and dissemination.

Why participants entered

Build with communities. Solve real challenges. Create resources that matter.

  • Translate complex science into clear, usable information.
  • Elevate real patient and clinician experiences.
  • Gain visibility with federal partners and the public.
  • Demystify HHS and build your network.
  • Retain full ownership of your work while enabling broad public impact through Creative Commons sharing of materials entered into the LymeX Visible Voices Prize.